Chancery Keeps Better Therapeutics SPAC Suit Alive
By Katryna Perera · October 18, 2024, 8:40 PM EDT
A Delaware vice chancellor on Friday refused to dismiss a suit challenging the take-public merger of now-defunct Better Therapeutics, saying the investors have sufficiently pleaded direct breach of fiduciary duty claims...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login